- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07939386
Comparison of the Effect of Lung-protective Ventilation on Optic Nerve Sheath Diameter in Obese and Non-obese Patients
Comparison of the Effect of Recruitment Maneuver and Individualized Positive End-expiratory Pressure on Optic Nerve Sheath Diameter in Obese and Non-obese Patients Undergoing Laparoscopic Surgery
The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers-employed as part of an intraoperative lung-protective ventilation strategy-and individualized positive end-expiratory pressure (PEEP) on intracranial pressure, as assessed by measuring the optic nerve sheath diameter, in both obese and non-obese patients undergoing laparoscopic surgery.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Laparoscopy is widely used due to its advantages, such as less blood loss, reduced postoperative pain, and faster recovery. However, pneumoperitoneum increases thoracoabdominal pressure, which decreases venous drainage from the brain and increases cerebral blood flow and intracranial pressure (ICP). The optic nerve sheath diameter (ONSD) measurement via ultrasound is a non-invasive and reliable method for assessing ICP.
The prevalence of obesity has increased substantially over recent decades, accompanied by a growing number of obese patients undergoing laparoscopic surgery. Obesity is associated with increased intra-abdominal pressure, which may contribute to an increase in ONSD. Furthermore, the additional rise in intra-abdominal pressure induced by pneumoperitoneum may exacerbate these effects, potentially placing obese patients at greater risk of alterations in cerebral haemodynamics during laparoscopic procedures.
Atelectasis occurs in roughly 90% of all patients undergoing general anaesthesia and can persist for weeks after operation. Intraoperative lung-protective ventilation has been recommended to reduce postoperative pulmonary complications after abdominal and/or laparoscopic surgery and also in obese patients. Decreasing compliance caused by surgical/ anaesthesia factors (i.e. pneumoperitoneum, positioning, and circuit disconnect) should be treated by appropriate interventions. Individualised PEEP and alveolar recruitment manoeuvres can prevent and reverse alveolar collapse, respectively.
However, the effects of these interventions on cerebral haemodynamics, particularly ICP as assessed indirectly by ONSD measurement, remain insufficiently understood in obese and non-obese patients undergoing laparoscopic surgery.
The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers and individualized PEEP- as part of intraoperative lung-protective ventilation strategy- on intracranial pressure, as assessed by measuring the optic nerve sheath diameter (ONSD), in both obese and non-obese patients undergoing laparoscopic surgery.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Gulay Erdogan Kayhan, Prof. Dr.
- Numéro de téléphone: 905332560011
- E-mail: drgulayer@yahoo.com
Sauvegarde des contacts de l'étude
- Nom: Muhammed Alpaslan Uludag, Research Assistant, MD
- E-mail: muho.78@live.com
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Patients over 25 years of age
- American Soc,ety of Anesthesiology (ASA) status I-III
- Scheduled to undergo laparoscopic abdominal surgery
- With an expected pneumoperitoneum duration of ≥1 hour
Exclusion Criteria:
- Patients with ocular disease
- Patients who have undergone cranial or ocular surgery
- Patients with a history of laparotomy
- Individuals with bullous lung disease
- Patients with uncontrolled chronic obstructive lung disease
- Patients with hemodynamic instability or decompensated heart failure
- Patients who require conversion to an open surgical procedure for any reason
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Diagnostique
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Autre: Group O
Obese patients with BMI ≥ 30 kg/m² |
Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting) ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value. |
|
Autre: Group N
Non-obese patients |
Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting) ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Optic nerve sheath diameter (ONSD)
Délai: Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
|
|
Optic nerve sheath diameter (ONSD)
Délai: Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
|
|
Optic nerve sheath diameter (ONSD)
Délai: Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
|
|
Optic nerve sheath diameter (ONSD)
Délai: Perioperative/Periprocedural (t3 - after desufflation)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t3 - after desufflation)
|
|
Optic nerve sheath diameter (ONSD)
Délai: Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
|
|
Optic nerve sheath diameter (ONSD)
Délai: Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
MAP
Délai: Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
|
Noninvasive mean arterial pressure (mmHg) |
Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
|
|
HR
Délai: Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
|
Heart rate (beat/min) |
Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
|
|
etCO2
Délai: Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)
|
End-tidal carbon dioxide levels (mmHg) |
Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Airway pressures during mechanical ventilation
Délai: Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
|
Ppeak, Pplato, Driving pressure (∆P), PEEP levels (cmH20) will be recorded from the sama ventilation monitor screen |
Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
|
|
Postoperative complications
Délai: PONV will be questioned at the 24th hours
|
Postoperative nause and vomiting (PONV) |
PONV will be questioned at the 24th hours
|
|
Postoperative complications
Délai: Headache will be questioned at the 24th hours
|
Headache |
Headache will be questioned at the 24th hours
|
|
Postoperative complications
Délai: Visual disturbance will be questioned at the 24th hours
|
Visual disturbance |
Visual disturbance will be questioned at the 24th hours
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- E-25403353-050.04-260108454
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .